Since the discovery of DNA, the central dogma of genetic translation has lured us in with a simple path from genes to illness. With the completion of the Human Genome Project, however, we were forced to begin to explore the limitations of the mutation model of illness and our assumptions about the biology behind illness and health. Despite this sobering reality, and the history of genetic studies of depression coming up empty-handed, many of the 30 million people in the United States taking medication still believe that genes play a role in their “disease.”
Frustration with the field’s current approach has been seeping into the industry. In 2017, Dr. Thomas Insel, former director of the National Institutes of Mental Health, said, “I spent 13 years at NIMH really pushing on the neuroscience and genetics of mental disorders, and when I look back on that I realize that while I think I succeeded at getting lots of really cool papers published by cool scientists at fairly large costs—I think $20 billion—I don’t think we moved the needle in reducing suicide, reducing hospitalizations, improving recovery for the tens of millions of people who have mental illness.”
Many gene candidate studies have been sifting through haystacks, trying to pinpoint the exact snippets of DNA sequence that might be causing you to feel lethargic, unmotivated, and generally terrible. Your depression, they say, is your own DNA betraying you.
A new study is helping us understand how the field’s previous genetically-inclined direction of study might have been nothing more than a distraction.
Study Finds No Correlation Between Genes and Depression
A recently published study in the American Journal of Psychiatry found no support for the association between genetic polymorphisms and the development of “major depressive disorder.” A team of Colorado researchers compiled data gathered from the UK Biobank (with more than 502,682 individuals from 22 centers across the UK between 2006 and 2010) and closely examined 18 candidate genes hypothesized to be genetic underpinnings of depression and found that previous depression candidate gene findings were most likely Type 1 errors—or false positives.
Using the UK Biobank data, collected from online mental health questionnaires and DNA samples, the researchers were able to analyze the relationship between several depression phenotypes and moderators, and supposed genetic markers for the different manifestations of depression.
But more importantly, the researchers tried to replicate the results of studies that have implicated the top 16 candidate genetic loci for causing depression. Performing analyses with a much larger sample size than those of previous false-positive studies, their results debunked the idea that these loci were actually linked to depression. Out of these 16, only three attained statistical significance, but those results are consistent with the low power to detect small associations.
Led by Richard Border and Dr. Matthew Keller, the research team suggested that the field should abandon the idea that depression is genetic.
“Our results demonstrate that historical depression candidate gene polymorphisms do not have detectable effects on depression phenotypes. Furthermore, the candidate genes themselves (with the possible exception of DRD2) were no more associated with depression phenotypes than genes chosen at random.”
Their study is the most comprehensive and well-powered investigation of historical candidate polymorphism and candidate gene hypotheses in depression to date.
What Had We Misunderstood?
How is it that the multitudes of previous peer-reviewed studies were able to be published with false-positive findings? There might be several reasons.
1. Most candidate gene research had small sample sizes.
Earlier candidate gene studies analyzed small sample sizes and were, simply, underpowered. Between 2000 and 2009, the median sample size of these studies was 345.
Without enough data points, though, the results of these studies don’t really mean anything, especially when trying to generalize a complex disorder to an entire population. That’s just basic statistics.
Even though the results of those studies might have revealed associations between genetic variations and depression, studies that gathered more data points have revealed no correlation. That could explain why targeted, well-powered genetic association studies of depression and others with larger samples didn’t support the candidate gene hypothesis. Genome-wide association studies have found that individual single-nucleotide polymorphisms across large samples exert small effects on genetically complex traits like depression.
2. Some of these studies used incorrect analytic methods and inadequate control designs.
Researchers have suggested that the majority of published candidate gene studies have actually used incorrect analytic methods and inadequate control for population stratification. Since genetic phenotypes can take lifetimes to manifest themselves, the multitudes of confounding factors make it difficult to properly design controls. Improper analytics and experimental designs would account for the inconsistent results that these types of studies have yielded over the years.
3. Clinical utility of identifying individual gene mutations is unclear.
Even if we could pinpoint individual gene mutations that caused depression, there’s no real point in doing so. Clinical utility has always been one of the critical limitations in building gene-environment models in psychiatry. Looking for gene markers might even be counterproductive to people’s healing, focusing efforts on allopathic medicine that seeks to marginalize the role of lifestyle factors in lieu of the one pill for one ill approach to symptom management.
4. Publication bias.
Over the past years, this body of literature has shown significant publication bias. For example, the top nine of the 18 identified genes in the American Journal of Psychiatry study accounted for 86.59 percent of the studies. When so much effort and time is going into chasing these biomarkers, it’s easy for an entire field to get tunnel vision.
So Now What?
As humans, we’re inclined to seek certainty and answers—but this study shows that the answers to questions about the origins of depression are not in our DNA.
Through the lens of the root-cause resolution, depression can be seen as an invitation to explore imbalances that can range from nutritional to psychospiritual. We should be moving past a reductive and misleading interpretation of depression to understanding that our bodies create symptoms when things are out of alignment.
Depression is that symptom—indicating to us that our lifestyles are often a mismatch with our biology. We don’t need drugs to “fix” depression. The way out of depression doesn’t require new ancestry, it can be found through simple steps toward self-ownership and attending to lifestyle habits that are asking to be transformed.
Kelly Brogan, MD, is a holistic women’s health psychiatrist and author of The New York Times bestselling book “A Mind of Your Own,” the children’s book “A Time for Rain,” and co-editor of the landmark textbook “Integrative Therapies for Depression.” This work is reproduced and distributed with the permission of Kelly Brogan, MD. For more articles, sign up for the newsletter at www.KellyBroganMD.com
